Cases of COVID-19 are steadily rising in India, and because there is limited clinical experience around treatment options it becomes critical to share knowledge.
Indian Medical Association West Bengal welcomes doctors to a live clinical experience sharing recorded webinar session on “Different treatment options in COVID cases and role of Favipiravir in mild to moderate cases”
Highlights IMA West Bengal
Different treatment options in COVID cases and Role of Favipiravir in mild to moderate cases: Prof. Dr. Jyotirmoy Pal
●COVID-19 case definitions were explained
●Triage for patient management according to severity
●Management of patients with mild symptoms was described
●Essential investigations for mild cases
●Features seen on X-Ray in COVID-19 cases
●Features in progression from mild disease to moderate disease (clinical and laboratory markers)
Treatment of mild cases (symptomatic and specific)
Hydroxychroquine:
●Dosage in treatment and prophylaxis
Ivermectin:
●Guidelines and dosage
●Complications and side effects
●Evidence regarding use described
Doxycycline:
●Usability and complication
Favipiravir:
●Mechanism of action
●Indications of use
●Dosage and complications
●Side effects and interactions
●In detail discussion on when to refer to higher centre, when to discharge and regarding follow-up.
●Guidelines for home isolation
●6 min walk test procedure explained
Treatment of moderate case
●Additional investigations
●Radiological findings in CT scan
●Investigations to predict progression explained in detail
Management
●Oxygen therapy and fluid management
Tocilizumab
●Mechanism of action
●Indications of use
●Dosage and complications
●Side effects and interactions
Convalescent plasma:
●Emergency use approval, Experimental
Remdesivir (under emergency use authorization)
●Mechanism of action
●Indications of use
●Dosage and complications
●Side effects and interactions
Anticoagulation therapy
●Whom to start in?
●What to use?
●How long to continue?
●How to estimate Risk Stratification in Hospitals?
Heparin
●Dosage
●Monitoring during administration
Steroids
●When to use
●Dosage and precautions
●Adjustments for comorbid patients
Question and Answer session
We thank the Indian Medical Association West Bengal, for hosting this session. We also thank our sponsors Mylan Pharmaceuticals Pvt. Ltd. to make this program possible. Wish you a great learning experience.
